VANGUARD GROUP INC - 30 Sep 2025 SCHEDULE 13G/A Report for Cullinan Therapeutics Inc Common Stock (CGEM)

Filing Manager
VANGUARD GROUP INC
Reporting Manager
The Vanguard Group
Symbol
CGEM
Shares outstanding
59,102,912 shares
Disclosed Ownership
2,943,325 shares
Ownership
4.98%
Form type
SCHEDULE 13G/A
Filing time
30 Oct 2025, 14:57:38 UTC
Date of event
30 Sep 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
The Vanguard Group 4.98% 2,943,325 0 331,445 Ashley Grim Head of Global Fund Administration